HealthArs Live: The Rise of GLP-1 Drugs — Insights and Unknowns

Ars Technica Senior Health Reporter Beth Mole joins Daniel J. Drucker of the Lunenfeld Tanenbaum Research Institute to discuss the implications, insights, and remaining unknowns surrounding the widespread and rapid adoption of GLP-1 drugs.